Therapeutic potential of Liver Receptor Homolog-1 modulators

J Steroid Biochem Mol Biol. 2012 Jul;130(3-5):138-46. doi: 10.1016/j.jsbmb.2011.12.017. Epub 2012 Jan 14.

Abstract

Liver Receptor Homolog-1 (LRH-1; NR5A2) belongs to the orphan nuclear receptor superfamily, and plays vital roles in early development, cholesterol homeostasis, steroidogenesis and certain diseases, including cancer. It is expressed in embryonic stem cells, adult liver, intestine, pancreas and ovary. It binds to DNA as a monomer and is regulated by various ligand-dependent and -independent mechanisms. Recent work identified synthetic ligands for LRH-1; such compounds may yield useful therapeutics for a range of pathologic conditions associated with aberrant expression and activity of LRH-1.

Publication types

  • Review

MeSH terms

  • Animals
  • Cholesterol / metabolism
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism
  • Female
  • Humans
  • Male
  • Mice
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Ovary / drug effects
  • Ovary / metabolism
  • Phospholipids / metabolism
  • Rats
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism

Substances

  • NR5A2 protein, human
  • Nr5a2 protein, mouse
  • Phospholipids
  • Receptors, Cytoplasmic and Nuclear
  • Cholesterol